MoCA
MoCA is an intervention with 12 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
2
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
CAMCI: Advancing the Use of Computerized Screening in Healthcare
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study
Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom
Clinical Trials (12)
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
CAMCI: Advancing the Use of Computerized Screening in Healthcare
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study
Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study
Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom
Preoperative BAMCOG and Cortisol and Postoperative DeltaScan in AVR Patients (Aortic Valve Replacement)
Mechanochemical Ablation vs Thermal Ablation
Studying Cognition in SPG4
Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
Video Games to Track Cognitive Health
Listening Effort in Cochlear Implant Users
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
All 12 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 12